Gliflozins, also known as inhibitors of sodium-glucose co-transporter-2 (SGLT2), are one of several types of anti-diabetic medications (ADAs) having a proven track record of curing type-2 diabetes (T2D)1,26. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.